SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 423,356 shares at $25.84 ($11.3M) on 2023-01-12, disclosed to the SEC on 2023-01-17.
Open-market sale of $11.3M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.84 | 11,856 | $306K | 2.7% |
| 2 | $25.84 | 11,856 | $306K | 2.7% |
| 3 | $26.70 | 105,623 | $2.8M | 25.1% |
| 4 | $26.70 | 105,623 | $2.8M | 25.1% |
| 5 | $26.54 | 94,199 | $2.5M | 22.2% |
| 6 | $26.54 | 94,199 |
| $2.5M |
| 22.2% |
| Total | $26.58 avg | 423,356 | $11.3M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |